Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence - Gilgun-Sherki_2016_Drug.Alcohol.Depend_166_13 |
| Author(s) : Gilgun-Sherki Y , Eliaz RE , McCann DJ , Loupe PS , Eyal E , Blatt K , Cohen-Barak O , Hallak H , Chiang N , Gyaw S |
| Ref : Drug Alcohol Depend , 166 :13 , 2016 |
| Abstract : Gilgun-Sherki_2016_Drug.Alcohol.Depend_166_13 |
| ESTHER : Gilgun-Sherki_2016_Drug.Alcohol.Depend_166_13 |
| PubMedSearch : Gilgun-Sherki_2016_Drug.Alcohol.Depend_166_13 |
| PubMedID: 27394932 |
| Title : Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects - Cohen-Barak_2015_J.Clin.Pharmacol_55_573 |
| Author(s) : Cohen-Barak O , Wildeman J , van de Wetering J , Hettinga J , Schuilenga-Hut P , Gross A , Clark S , Bassan M , Gilgun-Sherki Y , Mendzelevski B , Spiegelstein O |
| Ref : Journal of Clinical Pharmacology , 55 :573 , 2015 |
| Abstract : Cohen-Barak_2015_J.Clin.Pharmacol_55_573 |
| ESTHER : Cohen-Barak_2015_J.Clin.Pharmacol_55_573 |
| PubMedSearch : Cohen-Barak_2015_J.Clin.Pharmacol_55_573 |
| PubMedID: 25524052 |